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The bacterial acquired immune system consists of clustered regularly interspaced short palindromic
repeats (CRISPRs) and CRIPSR-associated (Cas) genes, which include Cas-module repeat-associated
mysterious proteins (Cmr). The six Cmr proteins of Pyrococcus furiosus (pfCmr1–pfCmr6) form a
Cmr effector complex that functions against exogenous nucleic acid. Among the Cmr proteins, the
role of pfCmr5 and its involvement in the complex’s cleavage activity have been obscure. The eluci-
dated pfCmr5 structure has two inserted a-helices compared with the other trimeric Cmr5 struc-
ture. However, pfCmr5 exists as a monomeric protein both in the crystalline state and in solution.
In vitro assays indicate that pfCmr5 interacts with pfCmr4. These structural and biophysical data
might help in understanding the complicated and ill-characterized Cmr effector complex.
Structured summary of protein interactions:
pfCmr4 and pfCmr5 bind by molecular sieving (View interaction)
pfCmr4 and pfCmr4 bind by molecular sieving (View interaction)
pfCmr5 and pfCmr4 bind by ion exchange chromatography (View interaction)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction In Pyrococcus furiosus, small crRNAs and the repeat-associatedIn bacteria and archaea, clustered regularly interspaced short
palindromic repeats (CRISPRs) and CRIPSR-associated (Cas) pro-
teins confer heritable and adaptive immunity against incoming ge-
netic elements [1–5]. Among the two characteristic sequences in
the CRISPR locus, variable and conserved repeat sequences, the
information about the heritable and adaptive immunity is stored
in the variable sequences, which are derived from past encounters
and can be added from new exogenous genes [1,3,6,7].mysterious proteins (RAMPs) module-containing Cas proteins
(Cmr) form a Cmr effector complex, which cleaves complementary
exogenous target RNAs at a ﬁxed distance from the 30-end of the
integral crRNAs. The isolated Cmr effector complex from the crude
cell fraction of P. furiosus has been shown to contain six Cmr pro-
teins (pfCmr1–pfCmr6). However, the elimination of pfCmr5 in
the recombined effector complex leads to no observable effect on
the cleavage activity against added RNA [8]. The Cmr effector com-
plex in Sulfolobus solfataricus has also been conﬁrmed to have six
proteins (ssCmr1–ssCmr6). Furthermore, the complex includes an-
other protein, ssCmr7 [9]. These data invoke questions concerning
the composition of Cmr proteins and their roles in the effector
complex.
Detailed information on the Cmr5 protein has been obtained
from the recent crystal structure of Cmr5 from Thermus thermophilus
HB8 (ttCmr5). The protein forms a single globular structure of six
a-helices. Seven hydrophobic residues from the two neighboring
molecules form a hydrophobic interaction at the interfaces, which
has been suggested as a main force facilitating the assembly of a
trimeric ttCmr3 structure. Furthermore, its molecular size in solu-
tion is close to the trimeric protein. In addition, ttCmr5 has been
suggested to be a nucleic acid-binding protein based on the
Table 1
Data collection and reﬁnement statistics.
Parameters pfCmr5
Synchrotron BL17U1, SSRF
Wavelength (Å) 0.9762
Space group P43212
Cell parameters a = b = 53.94 Å, c = 235.99 Å, a = b = c = 90
Resolution (Å) 50.0–2.0 (2.03–2.0)
Completeness (%) 93.2 (85.4)
Rsym
a (%) 5.7 (46.5)
Reﬂections, total/unique 102, 154/23080
Rfactor
b (%)/Rfreec (%) 20.8/26.0
No. of atoms, protein/water 2, 423/183
rmsds, bonds Å/angles o 0.002/0.69
Geometry (%)
Favored 99.65
Allowed 0.35
Outliers 0
Values in parentheses are for the highest-resolution shell.
rmsds: root-mean-square deviations.
a Rsym =
P
hkl
P
j |Ij  hIi| /
P
hkl
P
jIj, where hIi is the mean intensity of reﬂection hkl.
b Rfactor =
P
hkl| |Fobs|  |Fcalc| |/
P
hkl| Fobs|, where Fobs and Fcalc are, respec-
tively, the observed and calculated structure factor amplitudes for the reﬂections
hkl included in the reﬁnement.
c Rfree is the same as Rfactor but is calculated over a randomly selected fraction
(8%) of the reﬂection data not included in the reﬁnement.
Fig. 1. The overall features of pfCmr5. (A) Structure-based sequence alignment of Cmr5s.
T. thermophilus HB8 (ttCmr5), Cmr5 from A. fulgidus (afCmr5), and Cmr5 from S. solfataric
amino acid sequence of pfCmr5. The continuous red-dotted lines above the aligned seque
the present structure. Identical residues are marked by ‘‘⁄’’. Conserved residues are indica
forming hydrophobic interactions at the interfaces of two subunits are indicated by bold i
the ClustalW2 program of the European Bioinformatics Institute and based on primar
represented as cylinders.
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subunit interface [10]. On the other hand, the crystal structure of
Cmr5 from Archaeoglobus fulgidus (afCmr5), which has been depos-
ited in the Protein Data Bank (PDB) and publicly released (PDB ID
2oeb at http://www.rcsb.org/pdb), contains a single molecule in
the asymmetric unit (ASU). However, a trimeric molecule cannot
be generated by applying the crystallographic H32 symmetry.
These data indicate that the biophysical properties of Cmr5 and
its role in the formation of the effector complex are still controver-
sial and should be investigated.
We elucidated the crystal structure of pfCmr5. A comparison
with ttCmr5 revealed the insertion of two a-helices in the middle
of the aligned sequence. Two molecules in the ASU cannot generate
a trimeric structure that has been shown in ttCmr5. Furthermore,
pfCmr5 behaved as a monomer in solution. Our in vitro binding as-
says exhibited the presence of a direct interaction between the
pfCmr5 and pfCmr4 proteins.
2. Materials and methods
2.1. Cloning, expression, and puriﬁcation of pfCmr5 and pfCmr4
The P. furiosus genes coding for pfCmr5 (Met1-Ser169, M.W.
19.7 kDa) and pfCmr4 (Met1-Lys295, M.W. 32.6 kDa) wereThe amino acid sequences are shown for Cmr5 from P. furiosus (pfCmr5), Cmr5 from
us (ssCmr5). The coils (a) stand for the a-helix. The numbering scheme follows the
nces display the extreme N-terminal and C-terminal regions that were not traced in
ted by ‘‘:’’ or ‘‘.’’, respectively. The residues in the a-helices are colored. The residues
n the dotted boxes of grey background. The sequence alignment was prepared using
y amino acid sequences [19]. (B) The overall shape of pfCmr5. The a-helices are
564 J.-H. Park et al. / FEBS Letters 587 (2013) 562–568ampliﬁed by polymerase chain reaction (PCR) using P. furiosus
chromosomal DNA as a template and primers designed for Liga-
tion-Independent Cloning [11]. The ampliﬁed PCR products were
prepared for vector insertion by puriﬁcation and treatment with
T4 DNA polymerase (New England Biolabs, Beverley, MA) in the
presence of 1 mM dTTP. The prepared inserts were annealed into
a derivative of pET21a (Novagen, Madison, WI) that expressed
the cloned gene fused with an N-terminal 6-His-Tobacco etch virus
(TEV) cleavage sequence. The expression constructs were trans-
formed into a Escherichia coli BL21(DE3)star strain, which was
grown in 1 l of LB medium containing ampicillin (100 lg/ml) at
310 K. After induction via the addition of 1.0 mM IPTG, the culture
medium was maintained for an additional 8 h at 310 K. The cells
were harvested by centrifugation at 5000g at 277 K. The cell pel-
let was resuspended in buffer A (20 mM Tris–HCl at pH 7.5 and
500 mM NaCl) and then disrupted by ultrasonication. The cell deb-
ris was removed by centrifugation at 11000g for 1 h. The fusion
protein was puriﬁed using a 5-ml HisTrap chelating column (GE
healthcare, Uppsala, Sweden). The column was extensively washed
with buffer A, and the bound protein was eluted with a linear gra-
dient of 0–500 mM imidazole in buffer A. After cleavage with the
recombinant TEV protease and removal of salts by dialysis against
buffer B (20 mM Tris–HCl at pH 7.5), the pfCmr5 protein wasFig. 2. A comparison of three revealed Cmr5 structures. (A) Three superposed Cmr5 str
pfCmr5 in green were superposed on the trimeric ttCmr5 in magenta. The common a-he
another aAII-helix in pfCmr5 and afCmr5 are labeled in green. (B) A comparison at the su
molecules (molA and molB) that mediate the oligomeric structure in ttCmr5 and corres
colors. The colors and labels used are the same as described in (A). (C) Analysis of
dehydrogenase (150 kDa), human serum albumin (66 kDa), and carbonic anhydrase (29puriﬁed using a 5 ml HiTrapSP cation exchange column (GE health-
care, Uppsala, Sweden). The column was extensively washed with
buffer B and the bound pfCmr5 was then eluted with approxi-
mately 150 mM NaCl in buffer B. On the other hand, pfCmr4 was
puriﬁed using a 5-ml HiTrapQ anion exchange column (GE health-
care, Uppsala, Sweden) and the bound pfCmr4 was then eluted
with approximately 400 mM NaCl in buffer B.
2.2. Crystallization, data collection, and structure determination of
pfCmr5
For crystallization, the puriﬁed pfCmr5 protein was concen-
trated to 12 mg/ml in a buffer consisting of 20 mM Tris–HCl at
pH 7.5 and 300 mM NaCl. The pfCmr5 crystals suitable for
diffraction experiments were obtained within 5 days using a hang-
ing-drop vapor-diffusion method at 22 C by mixing 1 ll each of
protein solution and reservoir solutions and equilibrating against
200 ll of reservoir solution, consisting of 20% (w/v) Polyethylene
Glycol 3350, 0.1 M Bis-Tris–HCl at pH 7.5, and 0.2 M Magnesium
Chloride. The diffraction data for the pfCmr5 crystal were collected
at the BL17U1 beamline of the Shanghai Synchrotron Radiation
Facility (SSRF) in China. The data were then indexed, integrated,
and scaled with the HKL-2000 suite [12]. The crystal structure ofuctures are displayed and labeled with discerned colors. The afCmr5 in orange and
lices of all three Cmr5s are labeled in black. The additional aAI-helix in pfCmr5 and
bunit interface of the trimeric ttCmr5 with pfCmr5. The non-polar residues from two
ponding residues in pfCmr5 are displayed with stick models and differentiated by
the oligomeric state of pfCmr5 by SEC. The protein standards used are alcohol
kDa). The proﬁle for the injected pfCmr5 is drawn with a blue line.
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ment program Phaser-1.3 [13] using the afCmr5 structure (PDB
ID 2oeb) as a search model. Further model building was performed
manually using the programsWinCoot [14] and O [15]. Reﬁnement
was performed with PHENIX [16] and CNS [17]. The statistics for
the collected data and reﬁnement are summarized in Table 1.
The quality of the model was analyzed withWinCoot [14] and Mol-
Probity [18]. Figures for the ribbon diagram and ball-and-stick
model were prepared using the PyMol Molecular graphics program
(Delano Scientiﬁc).
2.3. Size-exclusion chromatography (SEC) analysis
The SEC analyses for the puriﬁed pfCmr5, pfCmr4, and the mix-
ture of pfCmr4 and pfCmr5 were performed with an AKTA Explorer
chromatography system using a Superose 12 size-exclusion col-
umn (10  300 mm, GE healthcare, Sweden) in a buffer consisting
of 20 mM Tris–HCl at pH 7.5 and 100 mM NaCl at a ﬂow rate of
0.5 ml/min. The chromatograms were obtained by monitoring the
absorbance at 280 nm. A set of molecular mass standard markers
(Sigma, USA) ranging from 29 to 150 kDa was used.
2.4. Data deposition
The coordinates and structure factors of pfCmr5 were deposited
in the Protein Data Bank under the accession number 4gkf.
3. Results and discussion
3.1. Overall feature of pfCmr5
The pfCmr5 protein comprises 169 amino acids with a calcu-
lated theoretical molecular weight of approximately 20 kDa and
an isoelectric point (pI) of 8.61. The crystal structure of the recom-
binant pfCmr5 was solved by molecular replacement and reﬁned toFig. 3. Surface potential map of Cmr5. (A) Positively polarized surface 1. The positive
polarizing surfaces are indicated. The monomeric pfCmr5 and afCmr5 molecules are orie
(B) Negatively polarized surface 2 that is located on the opposite site to (A). This ﬁgurea resolution of 2.0 Å. In the reﬁned structure, ﬁve Gly residues from
the expression construct, thirteen (Glu2–Ile14) at the N-terminus,
and nine (Glu161–Ser169) at the C-terminus were disordered
(red-dotted line in Fig. 1A). An analysis of the modeled residues
by WinCoot [14] and MolProbity [18] indicated that they are lo-
cated in valid regions of the Ramachandran plot (Table 1).
The traced 146 amino acids of pfCmr5 form eight a-helices,
which comprise a single a-helical bundle structure (Fig. 1B). This
single globular structure is mainly formed by the hydrophobic
interaction between the central a4-helix and the seven surround-
ing a-helices. In addition to these hydrophobic interactions, polar
interactions were observed. For example, the hydroxyl group of
Tyr45 on the a2-helix interacts with the side chain of His110 on
the a4-helix, which is connected to the side chain of Glu32 on
the a1-helix through a water molecule. The side chain of Tyr108
on the a4-helix also interacts with Asn80 on the aAII-helix through
another water molecule.
3.2. Structural comparison of pfCmr5 with other Cmr5 structures
The pfCmr5 has approximately 25% and 35% sequence identity
with ttCmr5 and afCmr5 among the aligned 110 amino acids,
respectively. The relatively well-conserved residues are located
on the three a-helices, a2, a3, and a6 (Fig. 1A). These three a-heli-
ces are involved in assembling the trimeric ttCmr5 structure
(Fig. 2A). The other three a-helices, a1, a4, and a5, are oriented to-
wards the solvent at the opposite site to the trimeric axis in ttCmr5
(Fig. 2A) (10).
Three homologous proteins share a close structural similarity
(Fig. 2A), which is indicated by small values of root-mean-
square-deviations (rmsds) such as 1.5 and 1.4 Å among the com-
pared 100 Ca atoms. However, a closer look reveals several differ-
ences on the superposed structures. The pfCmr5 has additional
regions comprising approximately 10 amino acids at both the ex-
treme N- and the C-terminus, which includes a number of chargedly charged surfaces are colored in blue and red, respectively. The residues of the
nted in the same direction of the left-upper monomer of trimeric ttCmr5 molecule.
was obtained by 180 rotation of (A).
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(red-dotted lines in Fig. 1A) and are not conserved in both afCmr5
and ttCmr5. Therefore, their roles in pfCmr5 might be negligible or
be restrained.
The most remarkable difference can be found in the middle of
the structure-based aligned sequences. Upon comparison with
ttCmr5, the pfCmr5 has approximately 30 inserted residues be-
tween the a3- and a4-helices (Fig. 1A), compared with ttCmr5.
They form two a-helices of a short aAI and a three-turn aAII.
The afCmr5 has also a 20 amino-acid insertion at the correspond-
ing region, which forms a short aAII-helix and a long ﬂexible loop
(Fig. 2A). These inserted regions in both Cmr proteins are located at
the opposite site to the threefold axis of the superposed ttCmr
structure (Fig. 2A), implying that it may not be related to
oligomerization.
The third difference is found in their oligomeric states. The
ttCmr5 protein has been reported to form a trimeric structure by
the interaction of three a-helices (a2, a3, and a6) (Fig. 2A) [10].
More speciﬁcally, a hydrophobic interaction is formed at theFig. 4. Interaction of pfCmr5 with pfCmr4. (A) SEC of the puriﬁed pfCmr4. The proﬁle for t
mixed pfCmr5 and pfCmr4 proteins. Two independently puriﬁed proteins were mixed in v
500 mM NaCl gradient and were visualized using Coomassie Blue-stained 10% (w/v) SDS
Superose 12 10/300 GL is drawn with a blue line and the eluted fractions were visualizinterfaces of two molecules among the seven non-polar residues
(Leu38, Ala42, Phe50, and Al47 from one molecule and Leu87,
Leu88, and Leu91 from another molecule) (bold letters in Figs.
1A and 2B) on these three a-helices [10]. However, afCmr5 does
not appear to form a trimeric structure in the reported crystalline
state, nor does pfCmr5. To characterize the oligomeric state of
pfCmr5 in solution, we performed SEC, which exhibited a single
peak that eluted immediately after the referenced carbonic anhy-
drase (29 kDa) (Fig. 2C) and strongly indicated that 20-kDa pfCmr5
behaves as a monomeric protein in solution. At the primary se-
quence level, seven non-polar residues are not conserved and re-
placed with hydrophilic and bulky residues both in afCmr5 and
pfCmr5 (residues in the dotted boxes in Fig. 1A). At the structural
level, the main-chain atoms on the loop between the a2 and a3
helices of pfCmr5 are not well-superposed on those of ttCmr5
and the orientations of Tyr133 and Ser134 are located opposite
of the hydrophobic pocket (Fig. 2B), implicating that no hydropho-
bic interaction might be formed here. These sequential and struc-
tural features suggest that a tight hydrophobic interaction thathe injected pfCmr5 is drawn with a blue line. (B) Anion exchange chromatography of
itro and bound to the HiTrapQ anion exchange column, which was eluted using a 0–
–PAGE. (C) SEC of mixed pfCmr5 and pfCmr4 proteins. The elution proﬁle from the
ed using Coomassie Blue-stained 10% (w/v) SDS–PAGE.
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in pfCmr5 (Fig. 2C). It should also be noted that these hydrophobic
residues are not conserved in ssCmr5 and afCmr5 (Fig. 1A), indicat-
ing that the difference here may have a critical effect on the oligo-
merization of Cmr5 proteins.
Similarly in ttCmr5, the polar residues are localized, and
charged patches are formed on the pfCmr5 surface (Fig. 3). One
positively charged patch is formed at the entrance of the a1-helix
by the residues Arg15, Lys16, Arg20, and Arg21 along with Lys141
on the a6-helix. The basic character here might be increased by the
disordered, untraced residues Lys11 and Lys12. The Arg151 and
Arg152 residues form another small basic patch nearby. In the
vicinity of this positively charged patch, there is a negatively
charged patch formed by a number of acidic residues, Asp38,
Glu73, Asp100, Asp102, and Glu103 on one side and Glu32,
Asp35, Glu42, Glu43, and Glu160 on the other side. Interestingly,
two basic residues, Lys39 and Lys159, occupy the center of this
negatively charged patch. Overall, pfCmr5 and afCmr5 present less
electro-potentially polarized and delocalized surfaces than those of
ttCmr5, which has positively and negatively charged, localized sur-
faces, especially around the subunit interfaces at either side of tri-
meric structure (Fig. 3).
3.3. The pfCmr5 protein interacts with pfCmr4
We performed a number of in vitro assays to detect pfCmr5’s
biophysical interaction with other pfCmr proteins (Fig. 4). As men-
tioned in Methods, recombinant proteins of pfCmr5 and pfCmr4
were independently puriﬁed and mixed. Subsequently, anion ex-
change chromatography was carried out, which revealed two pro-
teins of uniform stoichiometry in several fractions (Fig. 4B). The
calculated pIs of pfCmr5 and pfCmr4 from their primary sequences
are 8.61 and 5.59, respectively. Therefore, the binding of pfCmr5 to
and the co-elution of two proteins from the anion exchange col-
umn at pH 7.5 strongly indicated the presence of direct interaction
between these two proteins.
Next, we performed SEC to further check the interaction be-
tween them. A pfCmr4 protein of approximately 33 kDa forms an
oligomeric protein in solution (Fig. 4A), although its exact oligo-
meric states cannot be identiﬁed. The SEC analysis of the mixture
of pfCmr5 and pfCmr4 exhibited two peaks (Fig. 4C) with two pro-
teins of the same stoichiometry via several fractions at the ﬁrst
peak and only the pfCmr5 at the second peak, which was excessive
when compared with pfCmr4 (Fig. 4C). These SEC data strongly
suggest that pfCmr5 directly interacts with pfCmr4. In addition, a
noticeable interaction with the other pfCmr proteins was not ob-
served in our tested conditions.
4. Concluding remarks
The Cmr5 is one of the widely distributed proteins in organisms
that have CRISPR adaptive immune systems including S. solfatari-
cus. The elucidated pfCmr5 structure demonstrates the conserva-
tion of a common a-helical bundle structure in Cmr5 proteins
(Fig. 1B), and its comparison with other Cmr5 structures indicates
the presence of structural variations in the intervening region
(Fig. 2A). In contrast to the trimeric structure of ttCmr5 (Fig. 2A),
pfCmr5 behaves as a monomeric protein both in the crystal and
solution (Fig. 2C). Seven non-polar residues that form the oligo-
meric structure at the subunit interface of the ttCmr5 trimer
(Fig. 1A) are not conserved in the structures of pfCmr5 and afCmr5
that form a monomeric structure. These hydrophobic sequences
are absent in ssCmr5 (Fig. 1A), indicating that ssCmr5 may exist
as a monomeric protein. A highly positively-charged localized sur-
face is formed at ttCmr5, which gives a clue concerning ttCmr5’srole as a nucleic acid-binding protein [10]. This surface is partially
conserved in the monomeric pfCmr5 and afCmr5. However, its
electro-potential is much weaker than that of ttCmr5 (Fig. 3A).
Many RAMP-module containing proteins, for example, Cmr pro-
teins, have been known to interact with RNA molecules. Therefore,
a RAMP module with a positively charged surface in pfCmr5 im-
plies that Cmr5 may function as an RNA-binding protein, or it
might help other Cmr proteins to bind RNA. The dispensability of
pfCmr5 in the cleavage function of the recombined Cmr effector
complex in P. furiosus [8] is suggestive of its eligibility as a member
of the effector complex. However, ssCmr5 takes part in forming the
Cmr effector complex in S. solfataricus [9]. Furthermore, pfCmr5
demonstrated direct interaction in solution with pfCmr4 (Fig. 4)
that was critical for the clearance of the add RNAs [8]. Therefore,
we suggest that pfCmr5 may inﬂuence the effector complex in a
yet unsolved way, for example, by affecting the RNA-binding afﬁn-
ity of the Cmr effector complex or the assembly of other Cmr pro-
teins. Nonetheless, the described data here is not enough to clarify
the role of pfCmr5. Further work is required for any deﬁnitive con-
clusion that explains the Cmr5 structural features and in vitro re-
sults described herein.
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